Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-30

FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for Montelukast Sodium by Amneal Pharmaceuticals LLC. This approval relates to an updated labeling or formulation under …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Montelukast Sodium (Montelukast Sodium)

Snippet

SUPPL AP for MONTELUKAST SODIUM (MONTELUKAST)